In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

by Brad Jones

Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

by Cheryl Platzman Weinstock

From the Editor-in-Chief

DNA profiling technologies are providing new ways to detect and monitor cancer.

by William G. Nelson, MD, PhD

Forward Look

Response to immunotherapy may be linked to gut microbiome.

by Chris Palmer

Forward Look

New guidelines account for limited medical resources.

by Cameron Walker

Forward Look

Efforts are underway to define role of high-dose radiation.

by Stephen Ornes

Healthy Habits

Developing healthy behaviors in young adulthood can help reduce cancer risk later in life.

by Brenda Conaway

Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.

by Stephen Ornes

Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.

by Sue Rochman

Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.

by Charlotte Huff